Global Central Venous Access Devices Market 2014-2018 - a new market research report on companiesandmarkets.com
PR-Inside.com: 2014-04-11 09:01:03
The Global Central Venous Access Devices market is forecast to grow at a CAGR of 4.10 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing aging population. The Global Central Venous Access Devices market has also been witnessing the increased use of antimicrobial catheters. However, the high risk of vein thrombosis could pose a challenge to the growth of this market.
Key vendors dominating this space are AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc., and Teleflex Inc.
Other vendors mentioned in the report are Boston Scientific Corp., Covidien Plc., Edwards Lifesciences Corp., Medical Components Inc., Smiths Medical, Terumo Corp., and Vygon Corp.
The following companies represent the key players in Global Central Venous Access Devices Market: AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc., and Teleflex Inc.
Following the change of reimbursement policies (offered under Medicare and Medicaid) in the recent past, there has been an increase in the use of antimicrobial catheters. According to the changes, reimbursement would no longer be provided for treatment of vascular access-related infections acquired during a patient´s hospitalization. The antimicrobial CVCs are inserted directly into the bloodstream through the large internal jugular, subclavian, and femoral veins, making them highly susceptible to infection. The complete CVC kits include maximum barrier drapes, manufactured catheter securement devices, and the antimicrobial agent (chlorhexidine) that is highly adopted by surgeons. The demand for dialysis catheters with intraluminal antimicrobial properties has also increased over the years. In addition, antimicrobial PICCs are extensively used to deliver chemotherapy and antibiotics as well as for drawing blood from immunocompromised patients.
One of the main drivers in this market is the increasing aging population that has led to an increase in demand for central venous access devices for delivering drugs, nutritional support, or aspiration of blood for sampling.
Further, one of the major challenges faced by the market is the high risk of vein thrombosis that can lead to a pulmonary embolism and may prove to be fatal.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.